DCTH has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
DCTH has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Days Inventory is also known as Days Sales of Inventory (DSI). Delcath Systems's Average Total Inventories for the three months ended in Dec. 2023 was $2.99 Mil. Delcath Systems's Cost of Goods Sold for the three months ended in Dec. 2023 was $0.17 Mil. Hence, Delcath Systems's Days Inventory for the three months ended in Dec. 2023 was 1,597.94.
The historical rank and industry rank for Delcath Systems's Days Inventory or its related term are showing as below:
During the past 13 years, Delcath Systems's highest Days Inventory was 1528.98. The lowest was 380.92. And the median was 483.46.
Delcath Systems's Days Inventory increased from Dec. 2022 (755.41) to Dec. 2023 (1,597.94). It might indicate that Delcath Systems's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year. Delcath Systems's Inventory Turnover for the three months ended in Dec. 2023 was 0.06.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Delcath Systems's Inventory-to-Revenue for the three months ended in Dec. 2023 was 5.56.
The historical data trend for Delcath Systems's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Delcath Systems Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Days Inventory | Get a 7-Day Free Trial | 383.78 | 430.30 | 616.58 | 907.18 | 1,528.98 |
Delcath Systems Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Days Inventory | Get a 7-Day Free Trial | 755.41 | 1,092.73 | 1,465.17 | 1,765.65 | 1,597.94 |
For the Medical Devices subindustry, Delcath Systems's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Delcath Systems's Days Inventory distribution charts can be found below:
* The bar in red indicates where Delcath Systems's Days Inventory falls into.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Delcath Systems's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as
Days Inventory (A: Dec. 2023 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (A: Dec. 2022 ) | + | Total Inventories (A: Dec. 2023 )) | / | count ) | / | Cost of Goods Sold (A: Dec. 2023 ) | * | Days in Period |
= | ( (1.998 | + | 3.322) | / | 2 ) | / | 0.635 | * | 365 |
= | 2.66 | / | 0.635 | * | 365 | ||||
= | 1,528.98 |
Delcath Systems's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:
Days Inventory (Q: Dec. 2023 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (Q: Sep. 2023 ) | + | Total Inventories (Q: Dec. 2023 )) | / | count ) | / | Cost of Goods Sold (Q: Dec. 2023 ) | * | Days in Period |
= | ( (2.667 | + | 3.322) | / | 2 ) | / | 0.171 | * | 365 / 4 |
= | 2.9945 | / | 0.171 | * | 365 / 4 | ||||
= | 1,597.94 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Delcath Systems (NAS:DCTH) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Delcath Systems's Inventory Turnover for the three months ended in Dec. 2023 is calculated as
Inventory Turnover | = | Cost of Goods Sold | / | Average Total Inventories |
= | 0.171 | / | 2.9945 | |
= | 0.06 |
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Delcath Systems's Inventory to Revenue for the three months ended in Dec. 2023 is calculated as
Inventory-to-Revenue | = | Average Total Inventories | / | Revenue |
= | 2.9945 | / | 0.539 | |
= | 5.56 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Thank you for viewing the detailed overview of Delcath Systems's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Vojo Vukovic | officer: See Remarks | C/O SYNTA PHARMACEUTICALS CORP., 45 HARTWELL AVENUE, LEXINGTON MA 02421 |
Gerard J Michel | director, officer: Chief Executive Officer | 420 CHIPETA WAY, SALT LAKE CITY UT 84108 |
Sandra Pennell | officer: See Remarks | C/O VERICEL CORPORATION, 64 SIDNEY STREET, CAMBRIDGE MA 02139 |
David L. Hoffman | officer: See Remarks | C/O DELCATH SYSTEMS, INC., 1633 BROADWAY, SUITE 22C, NEW YORK NY 10019 |
John Purpura | officer: EVP, Regulatory Affairs | 600 FIFTH AVENUE, 23RD FLOOR, NEW YORK NY 10020 |
John Richard Sylvester | director | C/O DELCATH SYSTEMS, INC., 1633 BROADWAY, SUITE 22C, NEW YORK NY 10019 |
Salamon Steven A J | director | 25 ADMIRAL ROAD, TORONTO A6 M5R 2L4 |
Rosalind Advisors, Inc. | director, other: See Remarks | 15 WELLESLEY STREET WEST, SUITE 326, TORONTO A6 M4Y 0G7 |
Kevin Muir | officer: See Remarks | C/O DELCATH SYSTEMS, INC., 1633 BROADWAY, SUITE 22C, NEW YORK NY 10019 |
Anthony Dias | officer: Vice President of Finance | C/O SEACHANGE INTERNATIONAL, 50 NAGOG PARK, ACTON MA 01720 |
Gil Aharon | director | 15 WELLESLEY STREET WEST, SUITE 326, TORONTO A6 M4Y 0G7 |
Johnny John | officer: See Remarks | C/O DELCATH SYSTEMS, INC., 1633 BROADWAY, SUITE 22C, NEW YORK NY 10019 |
Elizabeth Czerepak | director | 201 ROUTE 17 NORTH, RUTHERFORD NJ 07070 |
Christine Padula | officer: See Remarks | C/O DELCATH SYSTEMS, INC., 1633 BROADWAY, SUITE 22C, NEW YORK NY 10019 |
Simon Pedder | director | 1001 MAIN STREET, SUITE 600, BUFFALO NY 14203 |
From GuruFocus
By PRNewswire • 08-15-2023
By PRNewswire • 09-01-2023
By PRNewswire PRNewswire • 03-27-2023
By PRNewswire PRNewswire • 05-03-2023
By PRNewswire • 12-07-2023
By PRNewswire • 06-21-2023
By PRNewswire • 09-05-2023
By PRNewswire • 08-09-2023
By PRNewswire PRNewswire • 05-09-2023
By GuruFocus Research • 12-15-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.